Literature DB >> 10546981

Symptom dimensions in the course of childhood-onset schizophrenia.

D Bunk1, C Eggers, M Klapal.   

Abstract

The symptom dimensions of childhood-onset schizophrenia (COS) are described by focussing on the clinical features of 44 patients at onset of illness during the first episode and at follow-up investigation 42 years after onset. All subjects were re-diagnosed according to DSM IV. The symptomatology was evaluated with the Positive and Negative Symptom Scale (PANSS) at onset and at follow-up. Two principal component factor analyses with varimax-rotation were applied to the complete items set of the PANSS. The frequencies of positive, negative, and global symptoms were compared longitudinally in an ANOVA-repeated measures design. The factor analysis revealed 5 orthogonal symptom dimensions (factors) at onset of psychosis: Cognition, social withdrawal, antisocial behaviour, excitement, and reality distortion. At follow-up a five-factor solution was found, too, but different dimensions emerged: a positive, negative, excitement, cognitive, and anxiety/depression component which fits to the 5-factor model of White et al. (1997). The first psychotic episode of EOS is accompanied with more unspecific symptoms such as social withdrawal and antisocial behavior. In the later stages of (COS) the structure of symptom dimensions changes to that known from adult-onset schizophrenia (AOS). The results indicate that COS and AOS are comparable nosological entities and that more than 3 dimensions are required to describe the relevant clinical symptom structure. Positive and global symptoms decreased significantly during the course of illness. The frequencies of negative symptoms did not change which demonstrates their disabling impact.

Entities:  

Mesh:

Year:  1999        PMID: 10546981     DOI: 10.1007/pl00010688

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  42 in total

1.  Meta-analysis of symptom factors in schizophrenia.

Authors:  B S Grube; R M Bilder; R S Goldman
Journal:  Schizophr Res       Date:  1998-05-25       Impact factor: 4.939

Review 2.  Conceptualization of schizophrenia: the symptom-oriented approach.

Authors:  P Berner
Journal:  Psychopathology       Date:  1997       Impact factor: 1.944

3.  The long-term course of childhood-onset schizophrenia: a 42-year followup.

Authors:  C Eggers; D Bunk
Journal:  Schizophr Bull       Date:  1997       Impact factor: 9.306

4.  Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: Postnegative distinction and childhood predictors of adult outcome.

Authors:  M Maziade; S Bouchard; N Gingras; L Charron; A Cardinal; M A Roy; B Gauthier; G Tremblay; S Côté; C Fournier; P Boutin; M Hamel; C Mérette; M Martinez
Journal:  Br J Psychiatry       Date:  1996-09       Impact factor: 9.319

5.  Positive and negative subtypes of schizophrenia. A follow-up study from India.

Authors:  P Kulhara; K Chandiramani
Journal:  Schizophr Res       Date:  1990 Mar-Apr       Impact factor: 4.939

6.  Stability of positive and negative symptoms in schizophrenic patients: a 3-year follow-up study.

Authors:  S Dollfus; M Petit
Journal:  Eur Psychiatry       Date:  1995       Impact factor: 5.361

7.  Schizophrenia with childhood onset: a phenomenological study of 38 cases.

Authors:  W H Green; M Padron-Gayol; A S Hardesty; M Bassiri
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1992-09       Impact factor: 8.829

8.  Positive and negative subtypes of schizophrenia. A study from India.

Authors:  P Kulhara; S K Kota; S Joseph
Journal:  Acta Psychiatr Scand       Date:  1986-10       Impact factor: 6.392

9.  Replication of empirically derived syndromes as a basis for taxonomy of child/adolescent psychopathology.

Authors:  T M Achenbach; C K Conners; H C Quay; F C Verhulst; C T Howell
Journal:  J Abnorm Child Psychol       Date:  1989-06

10.  The structure of schizophrenic symptoms: a meta-analytic confirmatory factor analysis.

Authors:  D A Smith; C M Mar; B K Turoff
Journal:  Schizophr Res       Date:  1998-05-04       Impact factor: 4.939

View more
  5 in total

Review 1.  Categorical vs dimensional classifications of psychotic disorders.

Authors:  Melissa Potuzak; Caitlin Ravichandran; Kathryn E Lewandowski; Dost Ongür; Bruce M Cohen
Journal:  Compr Psychiatry       Date:  2012-06-07       Impact factor: 3.735

2.  Symptom dimensions and subgroups in childhood-onset schizophrenia.

Authors:  Kirsten E S Craddock; Xueping Zhou; Siyuan Liu; Peter Gochman; Dwight Dickinson; Judith L Rapoport
Journal:  Schizophr Res       Date:  2017-11-13       Impact factor: 4.939

3.  Trajectories of social withdrawal and cognitive decline in the schizophrenia prodrome.

Authors:  Kathryn Cullen; Angela Guimaraes; Jeffrey Wozniak; Afshan Anjum; S Charles Schulz; Tonya White
Journal:  Clin Schizophr Relat Psychoses       Date:  2011-01

4.  Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia.

Authors:  R S Wallwork; R Fortgang; R Hashimoto; D R Weinberger; D Dickinson
Journal:  Schizophr Res       Date:  2012-02-21       Impact factor: 4.939

5.  Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study.

Authors:  Konstantinos N Fountoulakis; Elena Dragioti; Antonis T Theofilidis; Tobias Wikilund; Xenofon Atmatzidis; Ioannis Nimatoudis; Erik Thys; Martien Wampers; Luchezar Hranov; Trayana Hristova; Daniil Aptalidis; Roumen Milev; Felicia Iftene; Filip Spaniel; Pavel Knytl; Petra Furstova; Tiina From; Henry Karlsson; Maija Walta; Raimo K R Salokangas; Jean-Michel Azorin; Justine Bouniard; Julie Montant; Georg Juckel; Ida S Haussleiter; Athanasios Douzenis; Ioannis Michopoulos; Panagiotis Ferentinos; Nikolaos Smyrnis; Leonidas Mantonakis; Zsófia Nemes; Xenia Gonda; Dora Vajda; Anita Juhasz; Amresh Shrivastava; John Waddington; Maurizio Pompili; Anna Comparelli; Valentina Corigliano; Elmars Rancans; Alvydas Navickas; Jan Hilbig; Laurynas Bukelskis; Lidija Injac Stevovic; Sanja Vodopic; Oluyomi Esan; Oluremi Oladele; Christopher Osunbote; Janusz Κ Rybakowski; Pawel Wojciak; Klaudia Domowicz; Maria Luisa Figueira; Ludgero Linhares; Joana Crawford; Anca-Livia Panfil; Daria Smirnova; Olga Izmailova; Dusica Lecic-Tosevski; Henk Temmingh; Fleur Howells; Julio Bobes; Maria Paz Garcia-Portilla; Leticia García-Alvarez; Gamze Erzin; Hasan Karadağ; Avinash De Sousa; Anuja Bendre; Cyril Hoschl; Cristina Bredicean; Ion Papava; Olivera Vukovic; Bojana Pejuskovic; Vincent Russell; Loukas Athanasiadis; Anastasia Konsta; Dan Stein; Michael Berk; Olivia Dean; Rajiv Tandon; Siegfried Kasper; Marc De Hert
Journal:  Int J Neuropsychopharmacol       Date:  2019-11-01       Impact factor: 5.176

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.